Evidence map›Paper›PMID 30298085›Full record

ReviewFrontiers in plant science2018

The Current Status and Development of Insect-Resistant Genetically Engineered Poplar in China.

Guiying Wang, Yan Dong, Xiaojie Liu, Guosheng Yao, Xiaoyue Yu, Minsheng Yang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in plant science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Cry1Ba1-mediated toxicity of transgenicFrontiers in insect science · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Optimization of theFrontiers in plant science · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Guiying WangInstitute of Forest Biotechnology, Forestry College, Agricultural University of Hebei, Baoding, China.
Yan DongInstitute of Forest Biotechnology, Forestry College, Agricultural University of Hebei, Baoding, China.
Xiaojie LiuLangfang Academy of Agriculture and Forestry Sciences, Langfang, China.
Guosheng YaoLangfang Academy of Agriculture and Forestry Sciences, Langfang, China.
Xiaoyue YuInstitute of Forest Biotechnology, Forestry College, Agricultural University of Hebei, Baoding, China.
Minsheng YangInstitute of Forest Biotechnology, Forestry College, Agricultural University of Hebei, Baoding, China.
Hebei Agricultural University · CNShijiazhuang Academy of Agriculture and Forestry Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poplar is one of the main afforestation tree species in China, and the use of a single, or only a few, clones with low genetic diversity in poplar plantations has led to increasing problems with insect pests. The use of genetic engineering to cultivate insect-resistant poplar varieties has become a hot topic. Over the past 20 years, there have been remarkable achievements in this area. To date, nearly 22 insect-resistant poplar varieties have been created and approved for small-scale field testing, environmental release, or pilot-scale production. Here, we comprehensively review the development of insect-resistant genetically modified (GM) poplars in China. This review mostly addresses issues surrounding the regulation and commercialization of

Indexed as

biosafetyinsect resistance genemultigene transformationtoxin protein expressiontransgenic poplar

Identifiers

PMID30298085
PMCPMC6160562
OpenAlexW2891558307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.